List of Studies ( Metabolite:TG 18:1_20:1_26:1)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004167 | AN006917 | Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells | Renal cancer cells | Human | Cancer | The Affiliated Cancer Hospital of Zhengzhou University | LC-MS |
| ST003760 | AN006174 | Untargeted lipidomics of combination gemcitabine/paclitaxel attenuated (CombAT) PDAC cells | Pancreas | Human | Cancer | Victor Chang Cardiac Research Institute | LC-MS |
| ST003758 | AN006170 | Untargeted lipidomics of gemcitabine-resistant cells | Pancreas | Human | Cancer | Victor Chang Cardiac Research Institute | LC-MS |
| ST003757 | AN006168 | Untargeted lipidomics of gemcitabine-resistant PDAC cells | Pancreas | Human | Cancer | Victor Chang Cardiac Research Institute | LC-MS |
| ST003452 | AN005668 | Integrated Proteomic and Lipidomic Analysis | Adipose tissue | Human | Obesity | Hamamatsu University School of Medicine | LC-MS |
| ST002967 | AN004875 | Lipidomics study of FASN inhibition in HT-29 and HCT 116 spheroids | Cultured cells | Human | Cancer | Ohio State University | LC-MS |
